PRESS RELEASE published on 10/09/2023 at 22:50, 1 year 1 month ago IGEA Pharma N.V.: IGEA to update on RBCARE business combination
PRESS RELEASE published on 10/03/2023 at 23:55, 1 year 1 month ago IGEA Pharma N.V.: IGEA and RBCARE2023 signed to combine their businesses
PRESS RELEASE published on 09/30/2023 at 19:15, 1 year 1 month ago IGEA Pharma N.V.: IGEA discloses its half-year figures 2023
PRESS RELEASE published on 09/28/2023 at 19:15, 1 year 1 month ago IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V.
PRESS RELEASE published on 08/30/2023 at 22:30, 1 year 2 months ago IGEA Pharma N.V.: IGEA filed the appeal on SIX decision of delisting
PRESS RELEASE published on 08/04/2023 at 22:30, 1 year 3 months ago IGEA Pharma N.V.: IGEA to update on SIX decision
PRESS RELEASE published on 07/31/2023 at 00:35, 1 year 3 months ago IGEA Pharma N.V.: IGEA discloses its Annual Report 2022
PRESS RELEASE published on 05/31/2023 at 22:35, 1 year 5 months ago IGEA Pharma N.V.: IGEA to apply for a further extension of its disclosure obligations
PRESS RELEASE published on 05/30/2023 at 01:00, 1 year 5 months ago IGEA Pharma N.V.: IGEA to update on strategic refocusing decisions.
PRESS RELEASE published on 05/15/2023 at 22:50, 1 year 6 months ago IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters
Published on 11/21/2024 at 10:03, 49 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 52 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 52 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 17 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 27 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 22 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 47 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 50 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 52 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 52 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 54 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 32 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 7 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 7 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
